Journal articles

2023

ref_biblio

David Balayssac, Julie Durif, Céline Lambert, Cristelle Dalbos, Eric Chapuy, et al.. Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine. Toxics, 2023, 11 (12), pp.1004. ⟨10.3390/toxics11121004⟩. ⟨hal-04332718⟩

Accès au texte intégral et bibtex

2022

ref_biblio

Sylvain Lamoine, Mélissa Cumenal, David Barriere, Vanessa Pereira, Mathilde Fereyrolles, et al.. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice. International Journal of Molecular Sciences, 2022, 23 (1), pp.98. ⟨10.3390/ijms23010098⟩. ⟨hal-03703118⟩

Accès au texte intégral et bibtex

2021

ref_biblio

Nicolas Kerckhove, Marie Selvy, Céline Lambert, Coralie Gonneau, Gabrielle Feydel, et al.. Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy. Frontiers in Pharmacology, 2021, 12, pp.1-10. ⟨10.3389/fphar.2021.744085⟩. ⟨hal-03498040⟩

Accès au texte intégral et bibtex

ref_biblio

Vanessa Pereira, Sylvain Lamoine, Mélissa Cuménal, Stéphane Lolignier, Youssef Aissouni, et al.. Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity. Molecular Neurobiology, 2021, 58 (7), pp.3575-3587. ⟨10.1007/s12035-021-02361-6⟩. ⟨hal-03511787⟩

Accès au bibtex

ref_biblio

Marie Selvy, Bruno Pereira, Nicolas Kerckhove, Jérôme Busserolles, Fadila Farsi, et al.. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists’ professional practices. Supportive Care in Cancer, 2021, 29 (7), pp.4033-4043. ⟨10.1007/s00520-020-05928-6⟩. ⟨hal-03299953⟩

Accès au bibtex

ref_biblio

Marie Selvy, Nicolas Kerckhove, Bruno Pereira, Fantine Barreau, Daniel Nguyen, et al.. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study. Frontiers in Pharmacology, 2021, 12, ⟨10.3389/fphar.2021.637593⟩. ⟨hal-03238418⟩

Accès au texte intégral et bibtex

2020

ref_biblio

Jérôme Busserolles, Stéphane Lolignier, Nicolas Kerckhove, Célian Bertin, Nicolas Authier, et al.. Replacement of current opioid drugs focusing on MOR-related strategies. Pharmacology and Therapeutics, 2020, 210, pp.107519. ⟨10.1016/j.pharmthera.2020.107519⟩. ⟨hal-03490336⟩

Accès au texte intégral et bibtex

ref_biblio

Jérôme Busserolles, Ismail Ben Soussia, Laetitia Pouchol, Nicolas Marie, Mathieu Meleine, et al.. TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects. British Journal of Pharmacology, 2020, 177 (20), pp.4782-4795. ⟨10.1111/bph.15243⟩. ⟨hal-03512213⟩

Accès au texte intégral et bibtex

ref_biblio

Mélissa Cuménal, Marie Selvy, Nicolas Kerckhove, Célian Bertin, Margaux Morez, et al.. The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials. Expert Opinion on Drug Safety, 2020, pp.1-18. ⟨10.1080/14740338.2021.1842871⟩. ⟨hal-02997543⟩

Accès au texte intégral et bibtex

ref_biblio

Dimitra Gkika, Stéphane Lolignier, Guillaume Grolez, Alexis Bavencoffe, Georges Shapovalov, et al.. Testosterone‐androgen receptor: The steroid link inhibiting TRPM8‐mediated cold sensitivity. FASEB Journal, 2020, 34 (6), pp.7483-7499. ⟨10.1096/fj.201902270R⟩. ⟨hal-03512394⟩

Accès au texte intégral et bibtex

ref_biblio

Marie Selvy, Mélissa Cuménal, Nicolas Kerckhove, Christine Courteix, Jérôme Busserolles, et al.. The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials. Expert Opinion on Drug Safety, 2020, 19 (6), pp.707-733. ⟨10.1080/14740338.2020.1764934⟩. ⟨hal-02997564⟩

Accès au texte intégral et bibtex

2019

ref_biblio

David André Barrière, Al Mahdy Hamieh, Ricardo Magalhães, Amidou Traore, Julie Barbier, et al.. Structural and functional alterations in the retrosplenial cortex following neuropathic pain. Pain, 2019, 160 (10), pp.2241-2254. ⟨10.1097/j.pain.0000000000001610⟩. ⟨hal-04327523⟩

Accès au bibtex

ref_biblio

Nicolas Kerckhove, Jérôme Busserolles, Trevor Stanbury, Bruno Pereira, Valérie Plence, et al.. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup. BMJ Open, 2019, 9 (6), pp.e027770. ⟨10.1136/bmjopen-2018-027770⟩. ⟨hal-02325112⟩

Accès au texte intégral et bibtex

2018

ref_biblio

Laura Poupon, Sylvain Lamoine, Vanessa Pereira, David Barriere, Stéphane Lolignier, et al.. Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin. Neuropharmacology, 2018, 140, pp.43-61. ⟨10.1016/j.neuropharm.2018.07.026⟩. ⟨hal-02065469⟩

Accès au texte intégral et bibtex

2017

ref_biblio

Delphine Vivier, Ismail Ben Soussia, Nuno Rodrigues, Stéphane Lolignier, Maïly Devilliers, et al.. Development of the First Two-Pore Domain Potassium Channel TWIK-Related K + Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity. Journal of Medicinal Chemistry, 2017, 60 (3), pp.1076-1088. ⟨10.1021/acs.jmedchem.6b01285⟩. ⟨hal-02390407⟩

Accès au bibtex

2016

ref_biblio

Stéphane Lolignier, Dimitra Gkika, David Andersson, Enrico Leipold, Irina Vetter, et al.. New Insight in Cold Pain: Role of Ion Channels, Modulation, and Clinical Perspectives. Journal of Neuroscience, 2016, 36 (45), pp.11435 - 11439. ⟨10.1523/jneurosci.2327-16.2016⟩. ⟨hal-03512571⟩

Accès au texte intégral et bibtex

ref_biblio

Stéphane Lolignier, Alain Eschalier, Caroline Bonnet, Patrick Delmas, Jérôme Busserolles. Le canal Nav1.9 : protéine clé pour la perception du froid et cible thérapeutique potentielle contre la douleur. Médecine/Sciences, 2016, 32 (2), pp.162 - 165. ⟨10.1051/medsci/20163202009⟩. ⟨hal-01795185⟩

Accès au texte intégral et bibtex

2015

ref_biblio

Stéphane Lolignier, Caroline Bonnet, Christelle Gaudioso, Jacques Noël, Jérôme Ruel, et al.. The Nav1.9 Channel Is a Key Determinant of Cold Pain Sensation and Cold Allodynia. Cell Reports, 2015, ⟨10.1016/j.celrep.2015.04.027⟩. ⟨hal-01208540⟩

Accès au texte intégral et bibtex

2014

ref_biblio

Nuno Rodrigues, Khalil Bennis, Delphine Vivier, Vanessa Pereira, Franck C. Chatelain, et al.. Synthesis and structure-activity relationship study of substituted caffeateesters as antinociceptive agents modulating the TREK-1 channel.. European Journal of Medicinal Chemistry, 2014, 75, pp.391-402. ⟨hal-00955551⟩

Accès au bibtex

2013

ref_biblio

Maïly Devilliers, Jérôme Busserolles, Stéphane Lolignier, Emmanuel Deval, Vanessa Pereira, et al.. Activation of TREK-1 by morphine results in analgesia without adverse side effects. Nature Communications, 2013, 4, ⟨10.1038/ncomms3941⟩. ⟨hal-01689367⟩

Accès au texte intégral et bibtex

ref_biblio

Bruno Vilar, Jérôme Busserolles, Bing Ling, Sophie Laffray, Lauriane Ulmann, et al.. Alleviating Pain Hypersensitivity through Activation of Type 4 Metabotropic Glutamate Receptor. Journal of Neuroscience, 2013, 33 (48), pp.18951-18965. ⟨10.1523/JNEUROSCI.1221-13.2013⟩. ⟨hal-02448295⟩

Accès au texte intégral et bibtex

2012

ref_biblio

David André Barrière, Jennifer Rieusset, Didier Chanteranne, Jérôme Busserolles, Marie-Agnès Chauvin, et al.. Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization. Pain, 2012, 153 (3), pp.553 - 561. ⟨10.1016/j.pain.2011.11.019⟩. ⟨hal-02645150⟩

Accès au bibtex

2011

ref_biblio

Juliette Descoeur, Vanessa Pereira, Anne Pizzoccaro, Amaury François, Bing Ling, et al.. Oxaliplatin‐induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Molecular Medicine, 2011, 3 (5), pp.266-278. ⟨10.1002/emmm.201100134⟩. ⟨hal-02370551⟩

Accès au texte intégral et bibtex

ref_biblio

Stéphane Lolignier, Muriel Amsalem, François Maingret, Françoise Padilla, Mélanie Gabriac, et al.. Nav1.9 Channel Contributes to Mechanical and Heat Pain Hypersensitivity Induced by Subacute and Chronic Inflammation. PLoS ONE, 2011, 6 (8), pp.23083. ⟨10.1371/journal.pone.0023083⟩. ⟨hal-01689907⟩

Accès au texte intégral et bibtex

2010

ref_biblio

Alexis Bavencoffe, Dimitra Gkika, Artem Kondratskyi, Benjamin Beck, Anne-Sophie Borowiec, et al.. The Transient Receptor Potential Channel TRPM8 Is Inhibited via the α2A Adrenoreceptor Signaling Pathway. Journal of Biological Chemistry, 2010, 285 (13), pp.9410-9419. ⟨10.1074/jbc.M109.069377⟩. ⟨hal-03060332⟩

Accès au texte intégral et bibtex

2009

ref_biblio

Jacques Noël, Katharina Zimmermann, Jérôme Busserolles, Emanuel Deval, Abdelkrim Alloui, et al.. The mechano-activated K+ channels TRAAK and TREK-1 control both warm and cold perception.. EMBO Journal, 2009, 28 (9), pp.1308-18. ⟨10.1038/emboj.2009.57⟩. ⟨hal-00418382⟩

Accès au bibtex

2006

ref_biblio

Jérôme Busserolles, Elyette Gueux, Bozena Balasinska, Yannick Piriou, Edmond Rock, et al.. In vivo antioxidant activity of procyanidin-Rich extracts from grape seed and pine (Pinus maritima) bark in rats. International Journal for Vitamin and Nutrition Research, 2006, 76 (1), pp.22-27. ⟨10.1024/0300-9831.76.1.22⟩. ⟨hal-02667841⟩

Accès au bibtex